top of page

Screenshot 2023-07-11 at 1.25.29 PM.png

Publications

Alugupalli KR. TLR4 Ligands in Typhoid Vi Polysaccharide Subunit Vaccines Contribute to Immunogenicity. ImmunoHorizons. 2024 Jan 1;8(1):29-34. doi: 10.4049/immunohorizons.2300085. PMID: 38180344; PMCID: PMC10832388

Alugupalli KR. A TLR4 ligand-based Adjuvant for Promoting the Immunogenicity of Typhoid Subunit Vaccines. Frontiers in Immunology 2024 15:1383476. doi: 10.3389/fimmu.2024.1383476. PMID: 38799439 PMCID: PMC11116679

Alugupalli KR. Monophosphoryl Lipid A-based Adjuvant to Promote the Immunogenicity of Multivalent Meningococcal Polysaccharide Conjugate Vaccines. ImmunoHorizons. 2024 Apr 1;8(4):317-325. doi: 10.4049/immunohorizons.2400013. PMID: 38625118; PMCID: PMC11066721

Alugupalli KR. Characterization of Turbo, a TLR Ligand-based Adjuvant for Glycoconjugate Vaccines. ImmunoHorizons. 2024 Aug 1;8(8):527-537. doi: 10.4049/immunohorizons.2400040. PMID: 39093309; PMCID: PMC11374753

kra@turbovaxinc.com

+1 856 283 1125

bottom of page